Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	697.50M
Revenue (ttm)	54.07M
Net Income (ttm)	13.83M
Shares Out	250.00M
EPS (ttm)	0.06
PE Ratio	50.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,399,171
Average Volume	2,029,181
Open	2.780
Previous Close	2.780
Day's Range	2.760 - 2.820
52-Week Range	1.070 - 4.900
Beta	0.51
RSI	44.65
Earnings Date	May 3, 2026

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC